New developments in anti-malarial target candidate and product profiles
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New developments in anti-malarial target candidate and product profiles
Authors
Keywords
Malaria, <em class=EmphasisTypeItalic >Plasmodium</em>, Elimination drug discovery, Eradication drug discovery, Medicines, Target candidate profile, Target product profile
Journal
MALARIA JOURNAL
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-01-13
DOI
10.1186/s12936-016-1675-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Artemisinin Resistance–Associated K13 Polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010–2015
- (2016) Costanza Tacoli et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- PI4 Kinase Is a Prophylactic but Not Radical Curative Target in Plasmodium vivax-Type Malaria Parasites
- (2016) Anne-Marie Zeeman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Luciferase-Based, High-Throughput Assay for Screening and Profiling Transmission-Blocking Compounds against Plasmodium falciparum Gametocytes
- (2016) Leonardo Lucantoni et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase
- (2016) Ebere Sonoiki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug Development
- (2016) James S. McCarthy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia
- (2016) Rithea Leang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial
- (2016) Bronner P. Gonçalves et al. BMC Medicine
- An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
- (2016) Rithea Leang et al. BMC Medicine
- Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell-induced vaso-occlusion
- (2016) Marilyn J. Telen et al. BRITISH JOURNAL OF HAEMATOLOGY
- High-Throughput Assay and Discovery of Small Molecules that Interrupt Malaria Transmission
- (2016) David M. Plouffe et al. Cell Host & Microbe
- The High Blood Pressure-Malaria Protection HypothesisNovelty and Significance
- (2016) Julio Gallego-Delgado et al. CIRCULATION RESEARCH
- PlasmodiumParasitemia Associated With Increased Survival in Ebola Virus–Infected Patients
- (2016) Kyle Rosenke et al. CLINICAL INFECTIOUS DISEASES
- Treatment regimens for pregnant women with falciparum malaria
- (2016) Brioni R. Moore et al. Expert Review of Anti-Infective Therapy
- Efficacy of OZ439 (artefenomel) against earlyPlasmodium falciparumblood-stage malaria infection in healthy volunteers
- (2016) James S. McCarthy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Piperaquine Monotherapy of Drug-SusceptiblePlasmodium falciparumInfection Results in Rapid Clearance of Parasitemia but Is Followed by the Appearance of Gametocytemia
- (2016) Cielo J. Pasay et al. JOURNAL OF INFECTIOUS DISEASES
- Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models
- (2016) Melissa A Penny et al. LANCET
- Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial
- (2016) Issaka Sagara et al. LANCET INFECTIOUS DISEASES
- Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
- (2016) Aung Pyae Phyo et al. LANCET INFECTIOUS DISEASES
- Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study
- (2016) Chanaki Amaratunga et al. LANCET INFECTIOUS DISEASES
- Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
- (2016) Robert S Wallis et al. LANCET INFECTIOUS DISEASES
- Mind the gap: residual malaria transmission, veterinary endectocides and livestock as targets for malaria vector control
- (2016) Carlos Chaccour et al. MALARIA JOURNAL
- Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates
- (2016) Shwu-Maan Lee et al. MALARIA JOURNAL
- A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study
- (2016) James S. McCarthy et al. MALARIA JOURNAL
- Routine in vitro culture of P. falciparum gametocytes to evaluate novel transmission-blocking interventions
- (2016) Michael J Delves et al. Nature Protocols
- Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria
- (2016) Nicholas J. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- A simple and efficient method for cryopreservation and recovery of viable Plasmodium vivax and P. falciparum sporozoites
- (2016) Naresh Singh et al. PARASITOLOGY INTERNATIONAL
- Phenotypic Screens in Antimalarial Drug Discovery
- (2016) Marisa L. Hovlid et al. TRENDS IN PARASITOLOGY
- A broad analysis of resistance development in the malaria parasite
- (2016) Victoria C. Corey et al. Nature Communications
- Development of drugs for severe malaria in children
- (2016) Phaik Yeong Cheah et al. International Health
- Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial
- (2016) Peter G. Kremsner et al. PLOS MEDICINE
- “Asymptomatic” Malaria: A Chronic and Debilitating Infection That Should Be Treated
- (2016) Ingrid Chen et al. PLOS MEDICINE
- Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial
- (2016) Joshua Kimani et al. PLoS One
- Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology
- (2016) Yuanyuan Li et al. Scientific Reports
- Quantifying the pharmacology of antimalarial drug combination therapy
- (2016) Ian M. Hastings et al. Scientific Reports
- High Antimalarial Efficacy of Dihydroartemisinin–Piperaquine on the China–Myanmar Border: The Calm Before the Storm
- (2015) Rick M. Fairhurst AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Optimizing Intradermal Administration of Cryopreserved Plasmodium falciparum Sporozoites in Controlled Human Malaria Infection
- (2015) Kirsten E. Lyke et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- The pathogenesis of pediatric cerebral malaria: eye exams, autopsies, and neuroimaging
- (2015) Terrie E. Taylor et al. Annals of the New York Academy of Sciences
- Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso
- (2015) Issaka Zongo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- No Robust Evidence of Lumefantrine Resistance
- (2015) Kamal Hamed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Open-Label, Single-Dose, Parallel-Group Study in Healthy Volunteers To Determine the Drug-Drug Interaction Potential between KAE609 (Cipargamin) and Piperaquine
- (2015) Daniel S. Stein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment
- (2015) Rithea Leang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia
- (2015) Erni J. Nelwan et al. BMC Medicine
- Plasmodium vivax Liver Stage Development and Hypnozoite Persistence in Human Liver-Chimeric Mice
- (2015) Sebastian A. Mikolajczak et al. Cell Host & Microbe
- HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans
- (2015) Christoph D. Spinner et al. INFECTION
- Estimation of the Antirelapse Efficacy of Tafenoquine, UsingPlasmodium vivaxGenotyping
- (2015) Hans-Peter Beck et al. JOURNAL OF INFECTIOUS DISEASES
- Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study
- (2015) Jana Held et al. LANCET INFECTIOUS DISEASES
- Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates
- (2015) Gloria P Gómez-Pérez et al. MALARIA JOURNAL
- Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya
- (2015) Stephanie Dellicour et al. MALARIA JOURNAL
- Malaria, anaemia and under-nutrition: three frequently co-existing conditions among preschool children in rural Rwanda
- (2015) Fredrick Kateera et al. MALARIA JOURNAL
- Reduced deformability of parasitized red blood cells as a biomarker for anti-malarial drug efficacy
- (2015) Xiaoyan Deng et al. MALARIA JOURNAL
- Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay
- (2015) María Linares et al. MALARIA JOURNAL
- Screening for an ivermectin slow-release formulation suitable for malaria vector control
- (2015) Carlos Chaccour et al. MALARIA JOURNAL
- Development of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccines
- (2015) Danielle I Stanisic et al. MALARIA JOURNAL
- Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania
- (2015) Rita Baiden et al. MALARIA JOURNAL
- In silico Screening for Identification of Novel Anti-malarial Inhibitors by Molecular Docking, Pharmacophore Modeling and Virtual Screening
- (2015) Sidra Batool et al. Medicinal Chemistry
- Fifteen years of interventions
- (2015) Janet Hemingway NATURE
- Hit and lead criteria in drug discovery for infectious diseases of the developing world
- (2015) Kei Katsuno et al. NATURE REVIEWS DRUG DISCOVERY
- Malaria medicines: a glass half full?
- (2015) Timothy N. C. Wells et al. NATURE REVIEWS DRUG DISCOVERY
- An analysis of the attrition of drug candidates from four major pharmaceutical companies
- (2015) Michael J. Waring et al. NATURE REVIEWS DRUG DISCOVERY
- Sub-National Targeting of Seasonal Malaria Chemoprevention in the Sahelian Countries of the Nouakchott Initiative
- (2015) Abdisalan Mohamed Noor et al. PLoS One
- A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
- (2015) Margaret A. Phillips et al. Science Translational Medicine
- Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial
- (2015) Harry Tagbor et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Long-acting antiviral agents for HIV treatment
- (2015) David A. Margolis et al. Current Opinion in HIV and AIDS
- A simple and predictive phenotypic High Content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds
- (2015) Leonardo Lucantoni et al. Scientific Reports
- A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes
- (2015) Martijn W. Vos et al. Scientific Reports
- Delayed haemolysis after artesunate treatment of severe malaria – Review of the literature and perspective
- (2015) Thierry Rolling et al. Travel Medicine and Infectious Disease
- Killing the hypnozoite – drug discovery approaches to prevent relapse inPlasmodium vivax
- (2015) Brice Campo et al. Pathogens and Global Health
- Targeting Human Transmission Biology for Malaria Elimination
- (2015) Sandra K. Nilsson et al. PLoS Pathogens
- The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs
- (2015) Natalie Jane Spillman et al. International Journal for Parasitology-Drugs and Drug Resistance
- Helping Chemists Discover New Antibiotics
- (2015) Mark A. T. Blaskovich et al. ACS Infectious Diseases
- A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery
- (2015) Maria Jesus Almela et al. PLoS One
- Comparative Assessment of Transmission-Blocking Vaccine Candidates against Plasmodium falciparum
- (2015) M. C. Kapulu et al. Scientific Reports
- Mutations in the P-Type Cation-Transporter ATPase 4, PfATP4, Mediate Resistance to Both Aminopyrazole and Spiroindolone Antimalarials
- (2014) Erika L. Flannery et al. ACS Chemical Biology
- A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
- (2014) F. Joel Leong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission
- (2014) Kelli L. Kuhen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins
- (2014) S. Jaureguiberry et al. BLOOD
- Efficacy and Safety of the Mosquitocidal Drug Ivermectin to Prevent Malaria Transmission After Treatment: A Double-Blind, Randomized, Clinical Trial
- (2014) A. L. Ouedraogo et al. CLINICAL INFECTIOUS DISEASES
- Tafenoquine at therapeutic concentrations does not prolong fridericia-corrected QT interval in healthy subjects
- (2014) Justin A. Green et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Opening the door to innovation
- (2014) Janine Schuurman et al. mAbs
- Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort
- (2014) Dominic Mosha et al. MALARIA JOURNAL
- Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics
- (2014) Sonja Ghidelli-Disse et al. MALARIA JOURNAL
- High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania
- (2014) Sungwa I Matondo et al. MALARIA JOURNAL
- A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission
- (2014) Michael Makanga MALARIA JOURNAL
- Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures
- (2014) Laurent Dembélé et al. NATURE MEDICINE
- Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
- (2014) Elizabeth A. Ashley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Spiroindolone KAE609 for Falciparum and Vivax Malaria
- (2014) Nicholas J. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Comparability of Controlled Human Plasmodium falciparum Infection by Mosquito Bite in Malaria-Naïve Subjects at a New Facility for Sporozoite Challenge
- (2014) Angela K. Talley et al. PLoS One
- (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance ofPlasmodium
- (2014) María Belén Jiménez-Díaz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Defining the biology component of the drug discovery strategy for malaria eradication
- (2014) Didier Leroy et al. TRENDS IN PARASITOLOGY
- Development of a transmission-blocking malaria vaccine: Progress, challenges, and the path forward
- (2014) Julia K. Nunes et al. VACCINE
- Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization
- (2013) Nicholas J. White ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Male and Female Plasmodium falciparum Mature Gametocytes Show Different Responses to Antimalarial Drugs
- (2013) Michael J. Delves et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Microscale Human Liver Platform that Supports the Hepatic Stages of Plasmodium falciparum and vivax
- (2013) Sandra March et al. Cell Host & Microbe
- 157 Cryopreservation of Plasmodium falciparum Sporozoites and Sanaria® PfSPZ Vaccine
- (2013) Adam Ruben et al. CRYOBIOLOGY
- Experimentally Induced Blood-Stage Plasmodium vivax Infection in Healthy Volunteers
- (2013) James S. McCarthy et al. JOURNAL OF INFECTIOUS DISEASES
- Malaria Transmission After Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine: A Randomized Trial
- (2013) Patrick Sawa et al. JOURNAL OF INFECTIOUS DISEASES
- Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study
- (2013) Alejandro Llanos-Cuentas et al. LANCET
- Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial
- (2013) Alice C Eziefula et al. LANCET INFECTIOUS DISEASES
- A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso
- (2013) Alfred B Tiono et al. MALARIA JOURNAL
- Access to artemisinin-based anti-malarial treatment and its related factors in rural Tanzania
- (2013) Rashid A Khatib et al. MALARIA JOURNAL
- Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials
- (2013) Stephan Duparc et al. MALARIA JOURNAL
- Designing the next generation of medicines for malaria control and eradication
- (2013) Jeremy N Burrows et al. MALARIA JOURNAL
- A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
- (2013) Frédéric Ariey et al. NATURE
- The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases
- (2013) Thomas Spangenberg et al. PLoS One
- Quantitative Bioluminescent Imaging of Pre-Erythrocytic Malaria Parasite Infection Using Luciferase-Expressing Plasmodium yoelii
- (2013) Jessica L. Miller et al. PLoS One
- Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity
- (2013) R. Rochford et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Model System to Define Pharmacokinetic Requirements for Antimalarial Drug Efficacy
- (2013) R. P. Bakshi et al. Science Translational Medicine
- Feasibility, safety and effectiveness of combining home based malaria management and seasonal malaria chemoprevention in children less than 10 years in Senegal: a cluster-randomised trial
- (2013) R. C. K. Tine et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle
- (2013) Richard L. Shimp et al. VACCINE
- Development of humanized mouse models to study human malaria parasite infection
- (2012) Ashley M Vaughan et al. Future Microbiology
- Plasmodium falciparum parasitaemia in the first half of pregnancy, uterine and umbilical artery blood flow, and foetal growth: a longitudinal Doppler ultrasound study
- (2012) Jennifer B Griffin et al. MALARIA JOURNAL
- The complexities of malaria disease manifestations with a focus on asymptomatic malaria
- (2012) Dolie D Laishram et al. MALARIA JOURNAL
- Mosquito transmission of the rodent malaria parasite Plasmodium chabaudi
- (2012) Philip J Spence et al. MALARIA JOURNAL
- Shock and kill
- (2012) Steven G. Deeks NATURE
- P. falciparum In Vitro Killing Rates Allow to Discriminate between Different Antimalarial Mode-of-Action
- (2012) Laura M. Sanz et al. PLoS One
- Estimating the potential public health impact of seasonal malaria chemoprevention in African children
- (2012) Matthew Cairns et al. Nature Communications
- The Activities of Current Antimalarial Drugs on the Life Cycle Stages of Plasmodium: A Comparative Study with Human and Rodent Parasites
- (2012) Michael Delves et al. PLOS MEDICINE
- Ivermectin Mass Drug Administration to Humans Disrupts Malaria Parasite Transmission in Senegalese Villages
- (2011) Kevin C. Kobylinski et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- A Second Target of the Antimalarial and Antibacterial Agent Fosmidomycin Revealed by Cellular Metabolic Profiling
- (2011) Baichen Zhang et al. BIOCHEMISTRY
- Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination
- (2011) T. Bousema et al. CLINICAL MICROBIOLOGY REVIEWS
- A Simplified Intravenous Artesunate Regimen for Severe Malaria
- (2011) Peter Gottfried Kremsner et al. JOURNAL OF INFECTIOUS DISEASES
- Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study
- (2011) R McGready et al. LANCET INFECTIOUS DISEASES
- Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis
- (2011) Steven E Kern et al. MALARIA JOURNAL
- Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children
- (2011) Michael Nambozi et al. MALARIA JOURNAL
- Diversity-Oriented Synthesis Yields a Novel Lead for the Treatment of Malaria
- (2011) Richard W. Heidebrecht et al. ACS Medicinal Chemistry Letters
- A Research Agenda for Malaria Eradication: Drugs
- (2011) PLOS MEDICINE
- Arterolane, a New Synthetic Trioxolane for Treatment of UncomplicatedPlasmodium falciparumMalaria: A Phase II, Multicenter, Randomized, Dose‐Finding Clinical Trial
- (2010) Neena Valecha et al. CLINICAL INFECTIOUS DISEASES
- Waking the Sleeping Beauty
- (2010) François Nosten JOURNAL OF INFECTIOUS DISEASES
- Artemisinin‐Induced Dormancy inPlasmodium falciparum: Duration, Recovery Rates, and Implications in Treatment Failure
- (2010) Franka Teuscher et al. JOURNAL OF INFECTIOUS DISEASES
- Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial
- (2010) Arjen M Dondorp et al. LANCET
- Efficacy and safety of artemether–lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial
- (2010) Patrice Piola et al. LANCET INFECTIOUS DISEASES
- Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia
- (2010) Christine Manyando et al. MALARIA JOURNAL
- Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?
- (2010) Bernhards Ogutu et al. MALARIA JOURNAL
- Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination
- (2010) Timothy N.C. Wells et al. TRENDS IN PARASITOLOGY
- Chlorproguanil–Dapsone–Artesunate versus Chlorproguanil–Dapsone: A Randomized, Double-Blind, Phase III Trial in African Children, Adolescents, and Adults with Uncomplicated Plasmodium falciparum Malaria
- (2009) Alfred B. Tiono et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Improved Murine Model of Malaria Using Plasmodium falciparum Competent Strains and Non-Myelodepleted NOD-scid IL2R null Mice Engrafted with Human Erythrocytes
- (2009) M. B. Jimenez-Diaz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Simcyp®Population-based ADME Simulator
- (2009) Masoud Jamei et al. Expert Opinion on Drug Metabolism & Toxicology
- Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria
- (2009) Jean Ndiaye et al. MALARIA JOURNAL
- Chlorproguanil−Dapsone−Artesunate versus Artemether−Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria
- (2009) Zul Premji et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started